OSCIENT PHARMACEUTICALS CORPORATION as Issuer and GUARDIAN II ACQUISITION CORPORATION as Guarantor and U.S. BANK NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of [*] 12.50% Convertible Guaranteed Senior Notes Due 2011Indenture • November 21st, 2008 • Guardian II Acquisition CORP • Pharmaceutical preparations • New York
Contract Type FiledNovember 21st, 2008 Company Industry JurisdictionINDENTURE, dated as of [*], between Oscient Pharmaceuticals Corporation, a corporation duly organized and existing under the laws of The Commonwealth of Massachusetts, as Issuer (the “Company”), having its principal office at 1000 Winter Street, Suite 2200, Waltham, MA 02451, Guardian II Acquisition Corporation, a Delaware Corporation, having its principal office at 1000 Winter Street, Suite 2200, Waltham, MA 02451, as Guarantor (the “Guarantor”) and U.S. Bank National Association, a national banking association, as Trustee (the “Trustee”).
OSCIENT PHARMACEUTICALS CORPORATION as Issuer and GUARDIAN II ACQUISITION CORPORATION as Guarantor and U.S. BANK NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of [*] 12.50% Convertible Senior Notes Due 2011Indenture • November 7th, 2008 • Oscient Pharmaceuticals Corp • Pharmaceutical preparations • New York
Contract Type FiledNovember 7th, 2008 Company Industry JurisdictionINDENTURE, dated as of [*], between Oscient Pharmaceuticals Corporation, a corporation duly organized and existing under the laws of The Commonwealth of Massachusetts, as Issuer (the “Company”), having its principal office at 1000 Winter Street, Suite 2200, Waltham, MA 02451, Guardian II Acquisition Corporation, a Delaware Corporation, having its principal office at 1000 Winter Street, Suite 2200, Waltham, MA 02451, as Guarantor (the “Guarantor”) and U.S. Bank National Association, a national banking association, as Trustee (the “Trustee”).